WithMe Health Secures $20 Million Seed Funding to Replace Traditional PBMs with Innovative Medication Guidance Platform

VCBeat (WeChat ID: vcbeat) has learned that WithMe Health, a startup providing medication guidance services, recently announced a $20 million seed funding round from the venture capital firm Oak HC/FT. The funds will help the company expand its team, further develop its products and technology, and scale up its customer base.

WithMe Health is a company seeking to disrupt the $360 billion U.S. prescription drug industry. It was founded to address the increasingly severe challenges faced by employers and employees when using traditional Pharmacy Benefit Managers (PBMs). These challenges include inconsistent business models, impersonal interactions, high costs, and a lack of genuine transparency. WithMe Health aims to replace Pharmacy Benefit Managers (PBMs) with medication guidance solutions.

WithMe Health leverages modern technology and rich datasets, continuously applying validated scientific knowledge to create personalized medication experiences for employees and their families that are forward-looking, adaptive, convenient, and engaging. Through its innovative, outcome-driven business model, WithMe Health aligns incentives across the entire pharmaceutical value chain, optimizing health outcomes and healthcare value while significantly reducing costs for corporate employers.

Chris Price, Founder of WithMe Health and Partner at Oak HC/FT, stated, “Having worked in this industry for a long time, I know what is being done well, what could be done better, and what customers truly want. However, the current issue is that traditional business models and technological barriers have hindered transformation, resulting in no fundamental changes in the PBM market to address ongoing challenges and unmet needs. Even recent industry policies have only introduced incremental improvements to cope with regulatory pressures and unnecessary media scrutiny, rather than addressing the core issues faced by employers and their employees. This strong dissatisfaction with the status quo has motivated me to identify precise market demands and begin developing products within Oak HC/FT.”

“WithMe Health was founded by an innovative team with deep expertise in healthcare services, managed care, pharmacy benefit management (PBM), pharmaceutical supply chains, and health AI. It holds a unique advantage in the emerging category of medication guidance, and is even a pioneer in this field,” said Andrew Adams, Co-Founder and General Partner at Oak HC/FT. “We are thrilled to support WithMe.”

Concurrent with this financing round, Andrew Adams has joined the Board of Directors of WithMe Health, while Chris Price, Founder of WithMe Health and Partner at Oak HC/FT, serves as Chairman of the Board.

Currently, WithMe Health is in negotiations with an employer from the Fortune 100, which spends approximately $300 million annually on pharmaceuticals. The ideal outcome of these discussions is for both parties to commence their collaboration this year.

Oak HC/FT, led by the Healthcare and FinTech teams at Oak Investment Partners, is a venture capital growth equity fund that invests in high-tech healthcare and financial services companies. The firm is committed to driving industry transformation by providing entrepreneurs and companies with strategic advisory services, board-level business engagement, and access to a network of industry leaders.

Over the past decade, Oak HC/FT’s portfolio has comprised 20 companies, six of which have achieved valuations exceeding $1 billion.